Report overview
This report contains market size and forecasts of 3D Printing Drug Formulation and Administration in Global, including the following market information:
Global 3D Printing Drug Formulation and Administration Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global 3D Printing Drug Formulation and Administration market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
MED Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of 3D Printing Drug Formulation and Administration include Aprecia Pharmaceuticals, Triastek, FabRx, Multiply Labs, Merck KgaA, GlaxoSmithKline, Pfizer and Craft Health, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the 3D Printing Drug Formulation and Administration companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global 3D Printing Drug Formulation and Administration Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global 3D Printing Drug Formulation and Administration Market Segment Percentages, by Type, 2022 (%)
MED
FDM
SSE
Other
Global 3D Printing Drug Formulation and Administration Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global 3D Printing Drug Formulation and Administration Market Segment Percentages, by Application, 2022 (%)
Drugs
Dietary Supplement
Global 3D Printing Drug Formulation and Administration Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global 3D Printing Drug Formulation and Administration Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies 3D Printing Drug Formulation and Administration revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies 3D Printing Drug Formulation and Administration revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aprecia Pharmaceuticals
Triastek
FabRx
Multiply Labs
Merck KgaA
GlaxoSmithKline
Pfizer
Craft Health
